FDA’s final rule on citizen petitions makes only minor revisions to its proposed regulation, most notably shortening the agency’s response time from 180 days to 150 days.
The document instead is largely devoted to rejecting suggestions by the Pharmaceutical Research and Manufacturers of America to alter the scope of the regulation and its certification and verification requirements....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?